Omron Healthcare to introduce COMPLETE, first BP monitor with EKG capability Farhat Nasim15 April 2019 9:20 AM ISTComplete is an upper arm blood pressure (BP) monitor that allows users to simultaneously monitor EKG and blood pressure readings at home. U.S: Omron...
Sun Pharma launches cancer drug INFUGEM in US market Farhat Nasim9 April 2019 10:05 AM ISTSun Pharma said INFUGEM uses its proprietary technology which allows cytotoxic oncology products to be premixed in a sterile environment and supplied...
Torrent Pharma gets USFDA observations for Dahej plant Farhat Nasim9 April 2019 9:30 AM ISTTorrent Pharma announced that the audit at Dahej plant in Gujarat was carried out by US Food and Drug Administration (USFDA) in March 2019. New Delhi:...
GSK gets USFDA nod for HIV-1 drug branded as Dovato Farhat Nasim9 April 2019 9:20 AM ISTGSK already has two-drug regimen Juluca on the market, but only for the smaller market of HIV patients that have received prior treatment. Dovato is...
Zydus Cadila gets tentative USFDA nod to Lacosamide tablets to treat seizures Farhat Nasim8 April 2019 10:00 AM ISTLacosamide is an anti convulsant or anti-epileptic drug, used to prevent and control seizures. It works by reducing the spread of seizure activity in...
Zydus Cadila gets tentative USFDA nod to Tofacitinib tablets for treating arthritis Farhat Nasim6 April 2019 3:00 PM ISTTofacitinib is used alone or with other medications to treat moderate to severe forms of rheumatoid arthritis, the company said in a BSE filing. New...
US to wrap criminal trial of Insys Therapeutics' executives tied to opioid crisis Medical Dialogues Bureau6 April 2019 8:59 AM ISTBOSTON: Prosecutors on Thursday will present their closing arguments in the trial of the wealthy founder of pharmaceutical company Insys Therapeutics...
USFDA takes action to combat illegal online sale of opioids including Tramadol Medical Dialogues Bureau5 April 2019 9:15 AM ISTU.S: The U.S. Food and Drug Administration(USFDA) recently announced the issuance of two warning letters to operators of websites that illegally...
Novartis division resubmits USFDA application for biosimilar Pegfilgrastim Farhat Nasim4 April 2019 9:15 AM ISTNew Delhi: Novartis division, Sandoz, recently announced resubmission of its Biologics License Application (BLA) for a proposed biosimilar...
USFDA issues warning letter to Rajasthan based homeopathic firm and 3 others Farhat Nasim3 April 2019 9:25 AM ISTNew Delhi: The U.S. Food and Drug Administration (USFDA) recently posted warning letters to four companies producing homoeopathic drug products for...
Zydus Cadila gets tentative USFDA nod for Mirabegron ER tablets to treat overactive bladder Farhat Nasim2 April 2019 11:50 AM ISTThe company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Mirabegron extended-release...
Cipla gets 8 USFDA observations for Kurkumbh plant Farhat Nasim1 April 2019 9:55 AM ISTThe inspection covered three units at the plant. Post the conclusion of the inspection, the company received 8 GMP observations. The company also...
